Parkinsons Disease Psychosis Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | Tasly Pharmaceutical, Johns Hopkins University, Sumitomo Pharma America Inc., Vanda Pharmaceuticals, Acadia Pharmaceuticals Inc., Otsuka America

DelveInsight's "Parkinsons Disease Psychosis Market Insights, Epidemiology, and Market Forecast-2032″ report provides a comprehensive insight into the historical and projected epidemiology, along with market trends for Parkinsons Disease Psychosis in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.

To Know in detail about the Parkinsons Disease Psychosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Parkinsons Disease Psychosis Market Forecast
https://www.delveinsight.com/sample-request/parkinsons-disease-psychosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Parkinsons Disease Psychosis Market Report:
• The Parkinsons Disease Psychosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In Spetember 2024, Abbvie announced the results of the Phase 3 TEMPO-1 trial, which evaluated two daily doses (5 mg and 15 mg) of tavapadon, an oral dopamine receptor agonist. Both treatment groups outperformed the placebo in reducing disease burden by Week 26, as assessed by a composite score derived from sections of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
• Key Parkinsons Disease Psychosis Companies: Tasly Pharmaceutical, Johns Hopkins University, Sumitomo Pharma America Inc., Vanda Pharmaceuticals, Acadia Pharmaceuticals Inc., Otsuka America Pharmaceutical, Lundbeck LLC, Jazz Pharmaceuticals, Alkahest Inc., Sandoz, Sio Gene Therapies, Axovant Sciences Ltd., and others
• Key Parkinsons Disease Psychosis Therapies: pimavanserin tartrate, AGB101, and others
• The Parkinson's Disease epidemiology based on gender analyzed that in the US, males diagnosed with PD are higher in number than females
• The Parkinsons Disease Psychosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Parkinsons Disease Psychosis pipeline products will significantly revolutionize the Parkinsons Disease Psychosis market dynamics.

Parkinsons Disease Psychosis Overview
Parkinson's Disease Psychosis (PDP) is a non-motor symptom that affects some individuals with Parkinson's disease. It involves hallucinations (seeing or hearing things that aren't there) and delusions (false beliefs) as the disease progresses. These symptoms typically emerge later in the disease and can be triggered by Parkinson's medications or the underlying changes in brain chemistry caused by the disease. PDP significantly affects the quality of life for patients and caregivers, making treatment and management essential, often requiring adjustments to medications or specialized therapies.

Get a Free sample for the Parkinsons Disease Psychosis Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/parkinsons-disease-psychosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Parkinsons Disease Psychosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Parkinsons Disease Psychosis Epidemiology Segmentation:
The Parkinsons Disease Psychosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Parkinsons Disease Psychosis
• Prevalent Cases of Parkinsons Disease Psychosis by severity
• Gender-specific Prevalence of Parkinsons Disease Psychosis
• Diagnosed Cases of Episodic and Chronic Parkinsons Disease Psychosis

Download the report to understand which factors are driving Parkinsons Disease Psychosis epidemiology trends @ Parkinsons Disease Psychosis Epidemiology Forecast
https://www.delveinsight.com/sample-request/parkinsons-disease-psychosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Parkinsons Disease Psychosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Parkinsons Disease Psychosis market or expected to get launched during the study period. The analysis covers Parkinsons Disease Psychosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Parkinsons Disease Psychosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Parkinsons Disease Psychosis Therapies and Key Companies
• pimavanserin tartrate: Tasly Pharmaceutical
• AGB101: Johns Hopkins University

Discover more about therapies set to grab major Parkinsons Disease Psychosis market share @ Parkinsons Disease Psychosis Treatment Landscape
https://www.delveinsight.com/sample-request/parkinsons-disease-psychosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Parkinsons Disease Psychosis Market Strengths
• Increased awareness and a more in-depth understanding of the disease pathophysiology has improved diagnosis and treatment.
• The recent US FDA approval of NUPLAZID, the first approved therapy for treating hallucinations and delusions associated with PD Psychosis, indicates a positive change in treatment paradigm.

Parkinsons Disease Psychosis Market Opportunities
• There are opportunities for pharma players to develop therapies with improved safety and tolerability profiles, effectively reducing symptoms and preventing the recurrence of Psychosis in PD and AD.
• Advancement in biomarkers for cognitive decline allows precise diagnosis and individualized treatments

Scope of the Parkinsons Disease Psychosis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Parkinsons Disease Psychosis Companies: Tasly Pharmaceutical, Johns Hopkins University, Sumitomo Pharma America Inc., Vanda Pharmaceuticals, Acadia Pharmaceuticals Inc., Otsuka America Pharmaceutical, Lundbeck LLC, Jazz Pharmaceuticals, Alkahest Inc., Sandoz, Sio Gene Therapies, Axovant Sciences Ltd., and others
• Key Parkinsons Disease Psychosis Therapies: pimavanserin tartrate, AGB101, and others
• Parkinsons Disease Psychosis Therapeutic Assessment: Parkinsons Disease Psychosis current marketed and Parkinsons Disease Psychosis emerging therapies
• Parkinsons Disease Psychosis Market Dynamics: Parkinsons Disease Psychosis market drivers and Parkinsons Disease Psychosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Parkinsons Disease Psychosis Unmet Needs, KOL's views, Analyst's views, Parkinsons Disease Psychosis Market Access and Reimbursement

To know more about Parkinsons Disease Psychosis companies working in the treatment market, visit @ Parkinsons Disease Psychosis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/parkinsons-disease-psychosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Parkinsons Disease Psychosis Market Report Introduction
2. Executive Summary for Parkinsons Disease Psychosis
3. SWOT analysis of Parkinsons Disease Psychosis
4. Parkinsons Disease Psychosis Patient Share (%) Overview at a Glance
5. Parkinsons Disease Psychosis Market Overview at a Glance
6. Parkinsons Disease Psychosis Disease Background and Overview
7. Parkinsons Disease Psychosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Parkinsons Disease Psychosis
9. Parkinsons Disease Psychosis Current Treatment and Medical Practices
10. Parkinsons Disease Psychosis Unmet Needs
11. Parkinsons Disease Psychosis Emerging Therapies
12. Parkinsons Disease Psychosis Market Outlook
13. Country-Wise Parkinsons Disease Psychosis Market Analysis (2019-2032)
14. Parkinsons Disease Psychosis Market Access and Reimbursement of Therapies
15. Parkinsons Disease Psychosis Market Drivers
16. Parkinsons Disease Psychosis Market Barriers
17. Parkinsons Disease Psychosis Appendix
18. Parkinsons Disease Psychosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Parkinsons Disease Psychosis Epidemiology https://www.delveinsight.com/report-store/parkinsons-disease-psychosis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Parkinsons Disease Psychosis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Parkinsons Disease Psychosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Cart-related Neurotoxicity Market https://www.delveinsight.com/report-store/cart-related-neurotoxicity-nt-market
DelveInsight's "CART-related Neurotoxicity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the CART-related Neurotoxicity, historical and forecasted epidemiology as well as the CART-related Neurotoxicity market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
DelveInsight's "Crows Feet Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Crows Feet, historical and forecasted epidemiology as well as the Crows Feet market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

H3n2 Infection Market
https://www.delveinsight.com/report-store/h3n2-infection-market
DelveInsight's "H3N2 Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the H3N2 Infection, historical and forecasted epidemiology as well as the H3N2 Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Herpes Simplex Virus Market
https://www.delveinsight.com/report-store/herpes-simplex-market
DelveInsight's "Herpes Simplex Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Herpes Simplex, historical and forecasted epidemiology as well as the Herpes Simplex market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Hypercoagulability Market
https://www.delveinsight.com/report-store/hypercoagulability-market
DelveInsight's "Hypercoagulability Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypercoagulability, historical and forecasted epidemiology as well as the Hypercoagulability market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market
DelveInsight's "Liver Angiosarcoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Liver Angiosarcoma, historical and forecasted epidemiology as well as the Liver Angiosarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432,
State: Las Vegas NV 89107
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.